The molecular aspects in relation to GBM enroll mutations in telomerase reverse transcriptase (TERT) promoter, the amplification of the EGFR gene, and variations in chromosome copy numbers (+7/−10) [2]. This evidence concerns the gene EGFR and glioblastoma.